GenFleet Therapeutics (Shanghai)
Latest round
- Series C
Last raised
- Dec 2021
Total raised
- $168M
Investors
- 27
About GenFleet Therapeutics (Shanghai)
Founded in 2017 and based in Shanghai, China, GenFleet Therapeutics specializes in drug development focusing on oncology and immunology.GenFleet Therapeutics (Shanghai) Inc.39 per share at Hong Kong Stock Exchange under the ticker symbol "2595". GenFleet Therapeutics (Shanghai) Inc. provides oncology and immunology. The company's pipeline includes small and large molecule therapeutics targeting unvalidated clinical indications. The company product, Daberit® (Furazepirase), is the first KRAS G12C inhibitor approved in China and the third globally. The company generates revenue by researching and developing innovative therapeutic products, focusing on solid tumors, hematological malignancies, and autoimmune diseases and other related products.
Who invested in GenFleet Therapeutics (Shanghai)
27 investors across 5 rounds
See all investors in GenFleet Therapeutics (Shanghai)
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about GenFleet Therapeutics (Shanghai)
Who invested in GenFleet Therapeutics (Shanghai)?
GenFleet Therapeutics (Shanghai) has 27 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GenFleet Therapeutics (Shanghai) raised?
GenFleet Therapeutics (Shanghai) has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did GenFleet Therapeutics (Shanghai) last raise money?
GenFleet Therapeutics (Shanghai)'s most recent round on record is a Series C, in Dec 2021.
What does GenFleet Therapeutics (Shanghai) do?
Founded in 2017 and based in Shanghai, China, GenFleet Therapeutics specializes in drug development focusing on oncology and immunology.
Where is GenFleet Therapeutics (Shanghai) headquartered?
GenFleet Therapeutics (Shanghai) is headquartered in Shanghai, China.
Which VCs invest in companies like GenFleet Therapeutics (Shanghai)?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at GenFleet Therapeutics (Shanghai)'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like GenFleet Therapeutics (Shanghai)? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.